Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,745 | $15,443 | $18,147 | $21,626 |
| - Cash | $549 | $686 | $315 | $872 |
| + Debt | $7,087 | $5,498 | $4,714 | $4,773 |
| Enterprise Value | $23,283 | $20,255 | $22,546 | $25,527 |
| Revenue | $9,872 | $9,252 | $9,883 | $10,788 |
| % Growth | 6.7% | -6.4% | -8.4% | – |
| Gross Profit | $3,244 | $3,069 | $3,433 | $4,209 |
| % Margin | 32.9% | 33.2% | 34.7% | 39% |
| EBITDA | $1,894 | $1,732 | $1,820 | $3,159 |
| % Margin | 19.2% | 18.7% | 18.4% | 29.3% |
| Net Income | $871 | $854 | $946 | $1,995 |
| % Margin | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS Diluted | 7.69 | 7.52 | 7.98 | 15.53 |
| % Growth | 2.3% | -5.8% | -48.6% | – |
| Operating Cash Flow | $1,334 | $1,272 | $1,718 | $2,233 |
| Capital Expenditures | -$425 | -$408 | -$404 | -$403 |
| Free Cash Flow | $909 | $864 | $1,314 | $1,830 |